… and epigenetic profiles of AML patients. While new cytogenetic … prognosis for the majority of
patients with AML, outcomes are … minimal residual disease (MRD) that remains in the patient …

… assessment improves prediction of outcome in patients with chronic lymphocytic leukemia
(CLL) who achieve partial response: comprehensive analysis of two-phase III studies of the …

… and adults with ALL have shown that minimal residual disease (MRD) status is a strong …
residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia…

… leukemiaassociated phenotypic combinations exploitable for minimal residual disease detection
in other patient… genes is also potentially useful for detecting residual disease in ALL,3*4’ …

… sensitive and specific monitoring of residual disease (RD) in acute myeloid leukemia (AML). …
leukemia cell populations resolved by MFC (42 patients) and gains or losses of antigens on …

… For at least four decades, hematologists have known that the kinetics of early response to
therapy in patients with acute leukemia predicts the risk of relapse [1]. However, many …

… in adult patients with acute lymphoblastic leukemia, sometimes resulting in patients receiving
… We studied minimal residual disease (MRD) as a predictive factor for recurrence and as a …

… We used flow cytometry to quantify minimal residual disease (MRD) in 56 patients with acute
myeloid leukemia (AML) expressing a leukemia-associated phenotype. Thirty-four patients …

… Long-term outcomes after blinatumomab treatment: follow-up of a phase 2 study in patients
(pts) with minimal residual disease (MRD) positive B-cell precursor acute lymphoblastic …

… all patients at our institution who completed treatment of CLL … Patients who failed to respond
or died before treatment … -versus-leukemia effect can lead to continued depletion of residual …